alpha glucose/infarction

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 82 rezilta yo

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND The dipeptidyl peptidase-4 (DPP-4) inhibitors Sitagliptin and Vildagliptin lower blood glucose by augmenting endogenous levels of glucagon-like peptide-1 (GLP-1), an incretin which also confers cardioprotection. As such, we hypothesized that treatment with DPP-4 inhibitors are also

[Effect of a glucose-insulin-potassium mixture on the cyclic and adenine nucleotide levels in the acute period of myocardial infarct].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The development of myocardial infarction was shown to be accompanied by a rise in blood cAMP, cGMP and AMP levels, cyclic nucleotides peaking within the first hours of the disease. The increase in plasma cAMP, associated with developing heart failure, was more persistent. The administration of GIP

[Metabolic effects of a glucose-insulin-potassium mixture in acute myocardial infarct].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In order to limit the spread of myocardial infarction, 56 patients with acute myocardial infarction, admitted to hospital within 10 hours from the attack, were for two days treated with continuous intravenous drip infusion of glucose-insulin-potassium mixture (GIP) (300 ml glucose, 50 U common

[Effect of a glucose-insulin-potassium mixture on the size and clinical course of myocardial infarct].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In order to limit the spread of myocardial infarction, 56 patients with acute myocardial infarction, admitted to hospital within 10 hours after the attack, for two days received continuous intravenous drip infusion of glucose-insulin-potassium mixture (GIP) containing: 300 ml glucose, 50 U common

Pulmonary consolidation associated with infusion of a glucose-insulin-potassium solution in acute myocardial infarction.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

From 1972 to 1975, we have observed seven patients with localized pulmonary consolidation distal to the tip of a Swan-Ganz catheter. These seven instances occurred in a population of over 300 patients receiving a hypertonic solution of glucose, insulin, and potassium for acute myocardial infarction.

Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Clinical and experimental investigations demonstrated that metformin, a widely used anti-diabetic drug, exhibits cardioprotective properties against myocardial infarction. Interestingly, metformin was previously shown to increase the expression of PGC-1α a key controller of energy

[Dynamics of free fatty acids after a glucose load and the indices characterizing fatty tissue weight and function in acute myocardial infarct patients].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The relationship between the antilipolytic action of glucose and the parameters characterizing the weight and state of the adipose tissue was studied in 60 patients with acute myocardial infarction. The amount of fat in the body was assessed, and the morphological structure of the adipose tissue

Safety, tolerability, and efficacy of a glucose-insulin-potassium-magnesium-carnitine solution in acute myocardial infarction.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Fifty-four patients with AMI were treated with a front-loaded 15-hour infusion of hypertonic glucose, insulin, potassium, magnesium, and L-carnitine in addition to usual therapy. This metabolic solution was well tolerated, free of serious side effects, and reduced the incidence of morbid events.

[Effect of a glucose-insulin-potassium mixture on the course and outcome of myocardial infarction].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Transcortical sensory aphasia following a left frontal lobe infarction probably due to anomalously represented language areas.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A 57-year-old right-handed man presented with speech disturbance 1 day prior to his admission. The standardized aphasia test batteries showed transcortical sensory aphasia. MRI revealed a left frontal and insular infarct. Positron emission tomography scans also revealed a glucose hypometabolism in

Methods for the control of diabetes after acute myocardial infarction.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Blood glucose control in patients with diabetes after myocardial infarction is often poor, and this may contribute to increased mortality in the diabetic patient. A retrospective review of the records of 71 diabetic patients admitted with suspected myocardial infarction, and managed using a variety

Controlled trial of urokinase in myocardial infarction. A European Collaborative Study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

341 patients with acute myocardial infarction have been treated in intensive or coronary care units. They were randomised into two groups, 172 receiving urokinase and 169 receiving a glucose infusion. Thereafter they were anticoagulated first with heparin and then for a year with oral

A glucose-insulin-potassium solution improves glucose intake in hypoxic cardiomyocytes by a differential expression of glucose transporters in a metabolic syndrome model.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Among the last consequences of metabolic syndrome are cardiovascular complications such as infarcts. The hypoxic heart switches its lipid-based metabolism to carbohydrates, and a glucose-insulin-potassium (GIK) solution can be the metabolic support to protect the organ. Due to the physiology and

Can the frequency of myocardial infarction be reduced during coronary artery operations.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A prospective experiment was carried out in 56 patients undergoing coronary artery revascularization to determine whether those having a glucose-insulin-potassium (GIK) perfusion during the procedure would have fewer myocardial infarctions (MI) compared with patients given a control perfusion of

Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE to investigate the association between admission hyperglycemia and myocardial damage in patients with ST-segment elevation myocardial infarction (STEMI) using Cardiac Magnetic Resonance (CMR). METHODS We analyzed 113 patients with STEMI treated with successful primary percutaneous coronary

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye